WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattCHAIRPERSON CEO2024-04-161,045$231.71
$242.14kSell
Martine A. RothblattCHAIRPERSON CEO2024-04-161,037$230.95
$239.49kSell
Martine A. RothblattCHAIRPERSON CEO2024-04-163,600$129.49
$466.16kBuy
Martine A. RothblattCHAIRPERSON CEO2024-04-161,263$232.91
$294.16kSell
Martine A. RothblattCHAIRPERSON CEO2024-04-16255$233.72
$59.60kSell
Martine A. RothblattCHAIRPERSON CEO2024-04-15321$233.64
$75.00kSell
Martine A. RothblattCHAIRPERSON CEO2024-04-15884$234.51
$207.31kSell
Raymond DwekDirector2024-04-153,000$235.08
$705.24kSell
Raymond DwekDirector2024-04-153,000$88.03
$264.09kBuy
Martine A. RothblattCHAIRPERSON CEO2024-04-15155$237.43
$36.80kSell

1 of 42

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc11.25%5,295,000$1.25BInstitution
Lilly Co Eli11.16%5,251,394$1.24BInsider
Vanguard Group Inc9.93%4,673,678$1.10BInstitution
Wellington Management Group LLP8.06%3,794,010$892.77MInstitution
Avoro Capital Advisors LLC6.08%2,858,888$672.72MInstitution
Fmr LLC4.93%2,321,040$546.16MInstitution
Renaissance Technologies LLC4.61%2,170,214$510.67MInstitution
State Street Corp4.14%1,947,177$458.19MInstitution
Janus Henderson Group PLC1.85%870,119$204.75MInstitution
Martine A. Rothblatt1.76%827,110$194.63MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.59%12.41%Net SellingNet Selling
SRPT73.88%26.12%Net BuyingNet Selling
INCY79.30%20.70%Net SellingNet Buying
TECH97.66%2.34%Net BuyingNet Selling
LEGN23.61%0.00%

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 93.76% institutional shareholders, 13.28% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.16% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $1.24B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.